INSM [NASD]
Insmed Incorporated
Index- P/E- EPS (ttm)-3.78 Insider Own1.10% Shs Outstand118.93M Perf Week10.80%
Market Cap2.49B Forward P/E- EPS next Y-3.10 Insider Trans-9.33% Shs Float116.58M Perf Month12.95%
Income-437.60M PEG- EPS next Q-0.89 Inst Own- Short Float9.81% Perf Quarter-11.30%
Sales201.40M P/S12.36 EPS this Y-28.70% Inst Trans3.46% Short Ratio9.95 Perf Half Y-21.58%
Book/sh1.01 P/B21.84 EPS next Y12.20% ROA-35.40% Target Price49.44 Perf Year-21.38%
Cash/sh5.63 P/C3.92 EPS next 5Y- ROE-111.80% 52W Range16.41 - 34.44 Perf YTD-19.02%
Dividend- P/FCF- EPS past 5Y-6.40% ROI-39.40% 52W High-34.05% Beta1.96
Dividend %- Quick Ratio5.50 Sales past 5Y- Gross Margin76.90% 52W Low38.39% ATR1.14
Employees613 Current Ratio6.00 Sales Q/Q32.10% Oper. Margin- RSI (14)64.39 Volatility5.22% 5.53%
OptionableYes Debt/Eq6.73 EPS Q/Q10.50% Profit Margin- Rel Volume0.29 Prev Close22.06
ShortableYes LT Debt/Eq6.73 EarningsMay 05 BMO Payout- Avg Volume1.15M Price22.71
Recom1.80 SMA2016.24% SMA5014.18% SMA200-6.84% Volume23,532 Change2.95%
Apr-27-22Initiated Goldman Buy $56
Dec-06-21Initiated JP Morgan Overweight $45
Oct-19-21Resumed Morgan Stanley Overweight $56 → $52
Oct-19-21Resumed Monness Crespi & Hardt Buy $52
Oct-08-21Initiated Cantor Fitzgerald Overweight $60
Apr-26-21Resumed Credit Suisse Outperform $60
Dec-17-20Initiated Berenberg Buy $48
Oct-12-20Resumed Stifel Buy $44
Sep-03-19Initiated Goldman Buy $30
Apr-09-19Reiterated H.C. Wainwright Buy $43 → $52
Feb-15-19Upgrade JMP Securities Mkt Perform → Mkt Outperform $40
Jan-17-19Upgrade Goldman Neutral → Buy
Jan-02-19Initiated Canaccord Genuity Buy $20
Aug-06-18Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jul-23-18Initiated Goldman Neutral $32
Apr-23-18Upgrade Credit Suisse Neutral → Outperform
Mar-21-18Initiated Morgan Stanley Overweight $39
Jan-18-18Initiated Credit Suisse Neutral $31
Sep-05-17Reiterated Evercore ISI Outperform $28 → $40
Aug-17-17Initiated Evercore ISI Outperform $28
Jun-09-22 09:42AM  
Jun-03-22 08:00AM  
May-23-22 08:00AM  
May-17-22 06:05PM  
08:00AM  
May-15-22 08:52AM  
May-06-22 08:00AM  
May-05-22 09:05AM  
07:30AM  
May-04-22 09:10PM  
Apr-28-22 03:02PM  
Apr-21-22 08:00AM  
Apr-07-22 08:00AM  
Mar-28-22 08:00AM  
Mar-04-22 08:00AM  
Mar-03-22 08:00AM  
Feb-17-22 08:25AM  
07:00AM  
Feb-10-22 03:01PM  
08:00AM  
Feb-04-22 04:05PM  
Jan-27-22 08:00AM  
Jan-08-22 08:52AM  
Jan-04-22 08:00AM  
Dec-29-21 12:20PM  
Dec-07-21 12:53PM  
Dec-06-21 08:00AM  
Nov-29-21 11:32AM  
Nov-15-21 10:43AM  
Nov-09-21 08:34AM  
Nov-05-21 08:00AM  
Nov-03-21 08:00AM  
Oct-29-21 05:30PM  
09:27AM  
Oct-28-21 04:05PM  
08:45AM  
07:30AM  
Oct-25-21 12:46PM  
Oct-21-21 03:02PM  
Oct-14-21 08:00AM  
Oct-05-21 08:00AM  
Sep-10-21 09:18AM  
Sep-09-21 07:13PM  
Sep-03-21 08:00AM  
Sep-01-21 08:00AM  
Aug-06-21 08:00AM  
07:23AM  
Aug-05-21 09:05AM  
07:30AM  
Jul-29-21 03:05PM  
Jul-27-21 10:00AM  
08:00AM  
Jul-19-21 12:08PM  
Jul-08-21 08:00AM  
Jun-04-21 08:00AM  
May-25-21 07:00AM  
May-19-21 04:05PM  
May-13-21 11:14AM  
May-11-21 01:54AM  
May-10-21 07:00AM  
May-07-21 08:00AM  
May-06-21 09:05AM  
07:30AM  
01:48AM  
May-02-21 05:22AM  
Apr-29-21 05:03PM  
Apr-22-21 11:00PM  
12:33PM  
08:00AM  
Apr-07-21 08:00AM  
Mar-23-21 05:00AM  
Mar-05-21 08:00AM  
Feb-25-21 07:30AM  
06:30AM  
Feb-24-21 08:00AM  
Feb-19-21 08:37AM  
07:30AM  
Feb-16-21 08:00AM  
Feb-12-21 08:00AM  
Jan-31-21 03:45AM  
Jan-22-21 03:08AM  
Jan-19-21 09:54AM  
Jan-05-21 08:00AM  
Jan-04-21 08:00AM  
Dec-29-20 08:30AM  
Dec-23-20 02:59AM  
Dec-22-20 08:30AM  
Dec-16-20 09:18AM  
08:30AM  
Dec-15-20 08:30AM  
Dec-14-20 09:59AM  
Dec-04-20 08:00AM  
Dec-03-20 08:50AM  
Dec-02-20 08:00AM  
Nov-29-20 06:44AM  
Nov-24-20 08:00AM  
Nov-13-20 08:00AM  
Nov-06-20 08:00AM  
Nov-02-20 08:00AM  
05:29AM  
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutrophil-mediated diseases; and Treprostinil Palmitil Inhalation Powder, an inhaled formulation of a treprostinil prodrug treprostinil palmitil for the treatment of pulmonary arterial hypertension and other rare pulmonary disorders. Insmed Incorporated was founded in 1988 and is headquartered in Bridgewater, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Smith Michael AlexanderGeneral Counsel, Senior VPMay 17Sale20.371,05521,49050,583May 18 04:07 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerMay 17Sale20.271,67033,85168,822May 18 04:07 PM
Lewis WilliamChair and CEOMay 17Sale20.185,996120,999255,828May 18 04:07 PM
Adsett RogerChief Operating OfficerMay 17Sale20.342,02241,127145,982May 18 04:10 PM
Adsett RogerChief Operating OfficerMay 16Sale18.451,39425,719148,004May 18 04:10 PM
Lewis WilliamChair and CEOMay 16Sale18.353,39862,353261,824May 18 04:07 PM
Bonstein SaraChief Financial OfficerMay 16Sale18.511,43326,52554,683May 18 04:10 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerMay 16Sale18.411,11420,50970,492May 18 04:07 PM
Flammer Martina M.D.Chief Medical OfficerMay 16Sale18.511,57429,13566,432May 18 04:07 PM
Smith Michael AlexanderGeneral Counsel, Senior VPMay 16Sale18.484338,00251,638May 18 04:07 PM
SHAROKY MELVIN MDDirectorMay 11Buy17.2020,000344,000262,621May 13 06:15 PM
Lewis WilliamChair and CEOMar 23Option Exercise15.5696,6141,503,244283,029Mar 25 05:40 PM
Lewis WilliamChair and CEOMar 23Sale23.1696,6142,238,022217,624Mar 25 05:40 PM
Adsett RogerChief Operating OfficerJan 12Sale24.581,21729,914121,938Jan 13 04:41 PM
Bonstein SaraChief Financial OfficerJan 11Sale25.111,15428,97735,979Jan 13 04:41 PM
Flammer Martina M.D.Chief Medical OfficerJan 11Sale25.111,49537,53946,038Jan 13 04:41 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerJan 11Sale25.1192523,22756,961Jan 13 04:41 PM
Smith Michael AlexanderGeneral Counsel, Senior VPJan 11Sale25.1140710,22037,426Jan 13 04:41 PM
Lewis WilliamChair and CEOJan 11Sale25.112,87372,141217,624Jan 13 04:41 PM
Adsett RogerChief Operating OfficerJan 06Sale26.001,75945,734105,420Jan 07 04:28 PM
Smith Michael AlexanderGeneral Counsel, Senior VPJan 06Sale26.0038710,06228,375Jan 07 04:15 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerJan 06Sale26.001,61241,91248,428Jan 07 04:19 PM
Lewis WilliamChair and CEOJan 06Sale26.005,337138,762189,756Jan 07 04:25 PM
Lewis WilliamChair and CEOJan 05Sale27.617,126196,749195,093Jan 07 04:25 PM
Flammer Martina M.D.Chief Medical OfficerJan 05Sale27.611,42339,28933,345Jan 07 04:23 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerJan 05Sale27.611,50341,49850,040Jan 07 04:19 PM
Smith Michael AlexanderGeneral Counsel, Senior VPJan 05Sale27.6174920,68028,762Jan 07 04:15 PM
Adsett RogerChief Operating OfficerJan 05Sale27.613,06884,707107,179Jan 07 04:28 PM
Lewis WilliamChair and CEODec 27Option Exercise14.2446,614663,783248,833Dec 28 04:08 PM
Lewis WilliamChair and CEODec 27Sale27.7246,6141,292,140202,219Dec 28 04:08 PM
Lewis WilliamChair and CEODec 23Option Exercise13.5150,000675,296248,833Dec 28 04:08 PM
Lewis WilliamChair and CEODec 23Sale28.2150,0001,410,466202,219Dec 28 04:08 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerNov 01Option Exercise12.4461,000758,840112,514Nov 03 04:27 PM
ENGELSEN STEINAR JDirectorNov 01Buy30.1414,235429,043320,802Nov 03 04:26 PM
Brennan David RDirectorNov 01Buy30.1510,000301,50080,876Nov 03 04:27 PM
Schaeffer Orlov S NicoleChief People Strategy OfficerNov 01Sale30.2861,0001,847,35251,514Nov 03 04:27 PM
Lewis WilliamChair and CEOSep 30Option Exercise3.4096,614328,488298,833Oct 01 04:10 PM
Lewis WilliamChair and CEOSep 30Sale27.3696,6142,643,753202,219Oct 01 04:10 PM
SORIANO JOHNChief Compliance OfficerSep 07Option Exercise13.9117,349241,32552,553Sep 09 04:10 PM
SORIANO JOHNChief Compliance OfficerSep 07Sale28.2017,349489,24235,204Sep 09 04:10 PM